title: Rheumatoid arthritis: TAK-ing the road to suppress inflammation in synovial fibroblasts.
authors.affiliation: Centre of Experimental Rheumatology, Department of Rheumatology, University Hospital Zürich, Wagistrasse 14, 8952 Zürich, Switzerland.
authors.forename: Mojca
authors.initials: M
authors.lastname: Frank-Bertoncelj
authors.affiliation: Centre of Experimental Rheumatology, Department of Rheumatology, University Hospital Zürich, Wagistrasse 14, 8952 Zürich, Switzerland.
authors.forename: Steffen
authors.initials: S
authors.lastname: Gay
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000201:enzymology / Q000453:epidemiology / Q000378:metabolism; D017322:Clinical Trials, Phase II as Topic; D016207:Cytokines / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007783:Lactones / Q000008:administration & dosage / Q000627:therapeutic use; D020930:MAP Kinase Kinase Kinases / Q000187:drug effects*; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use; D012118:Resorcinols / Q000008:administration & dosage / Q000627:therapeutic use; D013583:Synovial Membrane / Q000166:cytology* / Q000378:metabolism; D000099151:MAP Kinase Kinase Kinase 7; D015025:Zearalenone / Q000008:administration & dosage
chemical_list: D016207:Cytokines; D007783:Lactones; D020930:MAP Kinase Kinase Kinases; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D011758:Pyrroles; D012118:Resorcinols; D000099151:MAP Kinase Kinase Kinase 7; C505734:7-oxozeanol; D015025:Zearalenone; C479163:tofacitinib